Rheumatology Advance Access originally published online on September 1, 2004
Rheumatology 2004 43(12):1555-1560; doi:10.1093/rheumatology/keh384
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology Vol. 43 No. 12 © British Society for Rheumatology 2004; all rights reserved
PAPER |
Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort
University of Maryland School of Medicine, Baltimore, MD, USA.
Correspondence to: J. Mikdashi, Division of Rheumatology and Clinical Immunology, 10 South Pine Street, Suite 834, Baltimore, MD 21201, USA. E-mail: jmikdash{at}umaryland.edu.
Objective. To identify factors predictive of significant neuropsychiatric (NP) damage in systemic lupus erythematosus (SLE).
Methods. One hundred and thirty patients with SLE were followed at the University of Maryland Lupus Clinic from 1992 until 2003. NP manifestations were defined according to the revised American College of Rheumatology (ACR) nomenclature and case definitions for NP–SLE syndromes. Disease activity was measured using the SLE Disease Activity Index (SLEDAI), organ damage using the Systemic Lupus International Collaborating Clinics Damage Index SLICC/ACR (SDI); NP damage (NPDI) was measured with the corresponding domain of the SDI. At end of study period, 64 patients exhibited no NP damage (NPDI = 0) and 66 patients developed significant NP damage (defined as NPDI 
1). The baseline features for these two patient groups were compared, and variables found to be significantly different were examined by multivariable analyses to determine their contribution to NP damage.
Results. Significant NP damage is common in SLE; mortality is infrequent and the cause of death is unrelated to NP damage. Independent predictors of significant NP damage were disease activity, Caucasian ethnicity and the presence of antiphospholipid antibodies and anti-Ro/SSA antibody. Certain clinical features at baseline predicted specific NP damage. For example, higher disease activity at baseline was predictive of psychosis and cognitive impairment, anti-dsDNA was predictive of polyneuropathy, and antiphospholipid antibodies were predictive of seizures and cerebrovascular accidents.
Conclusions. In this longitudinal SLE cohort, significant cumulative NP damage occurred. Early aggressive therapy targeted towards NP manifestations may prevent the occurrence of NP damage.
KEY WORDS: Systemic lupus erythematosus, Neuropsychiatric damage, Risk factors
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. M. Pego-Reigosa and D. A. Isenberg Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease Rheumatology, July 25, 2008; (2008) ken260v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Everett, T. D. Graves, S. Lad, H. R. Jager, M. Thom, D. A. Isenberg, and M. G. Hanna Aggressive CNS lupus vasculitis in the absence of systemic disease activity Rheumatology, January 1, 2008; 47(1): 107 - 109. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Avcin and E. Silverman Review: Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome Lupus, August 1, 2007; 16(8): 627 - 633. [Abstract] [PDF]
|
|
|
|
|
|
A.M. Bertoli, L.M. Vila, M. Apte, B.J. Fessler, H.M. Bastian, J.D. Reveille, and G.S. Alarcon Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage Lupus, June 1, 2007; 16(6): 410 - 417. [Abstract] [PDF]
|
|
|
|
|
|
L M Vila, M J Molina, A M Mayor, R A Peredo, M L Santaella, and S Vila Clinical and prognostic value of autoantibodies in Puerto Ricans with systemic lupus erythematosus Lupus, December 1, 2006; 15(12): 892 - 898. [Abstract] [PDF]
|
|